Skip to main content

Table 2 Mortality, weight, food and water intake, liver weight and histology in rats with D-galactosamine-induced acute liver failure with or without SLV338 treatment

From: Dual endothelin-converting enzyme/neutral endopeptidase blockade in rats with D-galactosamine-induced liver failure

 

Con

Con+SLV

GalN

GalN+SLV

N

9

9

19

22

Mortality (%)

0

0

42.9

37.1

Weight at injection of GalN (g)

304 ± 7

292 ± 3

300 ± 4

297 ± 3

Weight 48 h after GalN (g)

298 ± 8

298 ± 3

280 ± 6

283 ± 4

Food intake within 48 h after GalN (ml)

47 ± 0.2

49 ± 0.5*

20 ± 1.4***

26 ± 2.0***#

Water intake within 48 h after GalN (ml)

69 ± 1.9

89 ± 2.8***

55 ± 2.4**

65 ± 1.2*##

Liver weight (g)

10.5 ± 0.4

10.6 ± 0.2

9.5 ± 0.5

8.5 ± 0.4*

Liver necrosis score (0-3)

0.61 ± 0.3

0.22 ± 0.1

1.95 ± 0.2**

2.02 ± 0.2**

Liver inflammation score (0-3)

0 ± 0

0 ± 0

0.97 ± 0.2**

1.09 ± 0.2***

  1. Con, controls; SLV, SLV338; GalN, D-galactosamine.
  2. Data are means ± standard error of the mean.
  3. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Con. #p < 0.05, ##p < 0.01 vs. GalN.